Abstract:Frontotemporal dementia (FTD) is a fatal neurodegenerative disease characterized by changes in social and emotional behavior. The disease can be caused by mutations in GRN that result in haploinsufficiency of the neuronal and microglial protein progranulin. Recent findings using Grn-/- mice have directed attention to progranulin's function in microglia and its contribution to neuroinflammation. Grn-/- mice have FTD-related behavioral deficits and gliosis similar to the human disease, however they do not model progranulin haploinsufficiency. We sought to determine the relative effects of progranulin insufficiency on neurons and microglia in mouse models. In this study we tested the behavior, physiology, neuropathology, inflammatory mediators, and neuronal morphology in Grn+/- mice at different ages to investigate the relationship between neuroinflammation and neuronal dysfunction in FTD. Grn+/- mice displayed FTD-related behavioral deficits, similar to Grn-/- mice, without neuroinflammation. We found reduced social behavior in Grn+/- and Grn-/- mice using the three-chamber sociability test. This social deficit was constant between multiple cohorts on two separate genetic backgrounds and appeared to be age-dependent, with deficits emerging after 4 months. In addition to the three-chamber test, we observed abnormal social behavior in Grn+/- mice using the tube test of social dominance. We also found emotional impairments in Grn+/- and Grn-/- mice, evident by decreased freezing in a classical fear-condition paradigm. Whereas social/emotion impairment was clear, we found no hippocampal-dependent behavioral or electrophysiological impairment in Grn+/- mice. This is consistent with the relative preservation of other cognitive domains early in FTD.Gliosis and increased TNF-Î ± mRNA levels were not observed in Grn+/- mice, unlike Grn-/- mice, demonstrating a dissociation of neuroinflammation and neuronal dysfunction. Therefore, we analyzed neuronal morphology and found that Grn+/- mice, as well as Grn-/- mice, displayed abnormal dendritic architecture in the amygdala, a region that controls social/emotional behavior and is implicated in FTD. Our results demonstrate that neuroinflammation and microglial involvement are not a driving force in FTD due to progranulin haploinsufficiency and suggest a vital role for progranulin in neurons. Also, Grn+/- mice are a useful tool in studying the behavioral deficits in FTD.

A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

Losing protein in the brain: the case of progranulin

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias

Progranulin as a therapeutic target in neurodegenerative diseases

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort

The detection of GRN mutation carriers by progranulin blood protein levels from finger‐stick collection

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Neuronal Effects of Progranulin Deficiency Contribute to Frontotemporal Dementia Independent of Neuroinflammation

Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia

Lipid Dysregulation Unveil the Intricate Interplay of Lysosomal and Mitochondrial Changes in Frontotemporal Dementia with GRN Haploinsufficiency

Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases

Progranulin Gene Mutations in Chinese Patients with Frontotemporal Dementia: A Case Report and Literature Review

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Exaggerated Inflammation, Impaired Host Defense, and Neuropathology in Progranulin-Deficient Mice

The <i>FAM171A2</i> gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases

GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports

Progranulin mutations as risk factors for Alzheimer disease

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation